Safety concerns of angiotensin II receptor blockers in preschool children

Archives of Disease in Childhood

Volumn 96, Issue 9, 2011, Pages 881-882

  Tullus, Kjell ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; CREATININE; VALSARTAN;

ARTICLE; BRAIN EDEMA; CASE REPORT; CHILD; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTRITIS; GENERALIZED EDEMA; HUMAN; HYPERTENSION; INFANT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MALFORMATION; LUNG EDEMA; NEPHROTIC SYNDROME; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VIRAL GASTRITIS; VOMITING;

ACUTE KIDNEY INJURY; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; GASTROENTERITIS; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; TETRAZOLES; VALINE; VIRUS DISEASES;

EID: 80051803896     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300172     Document Type: Article

References (11)

1. Matchar D.B., McCrory D.C., Orlando L.A., et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008;148:16-29. (Pubitemid 351664943)
2. Lurbe E., Cifkova R., Cruickshank J.K., et al; European Society of Hypertension. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009;27:1719-1742
3. Herder S.D., Weber E., Winkemann A., et al. Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents. Pediatr Nephrol 2010;25:801-811
4. Webb N.J., Lam C., Loeys T., et al. Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol 2010;5:417-424
5. Neutel J.M. Clinical studies of CS-866, the newest angiotensin II receptor antagonist. Am J Cardiol 2001;87:37C-43C. (Pubitemid 32385761)
6. Flynn J.T., Meyers K.E., Neto J.P., et al.; Pediatric Valsartan Study Group. Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension 2008;52:222-228
7. Schaefer F., van de Walle J., Zurowska A., et al.; Candesartan in Children with Hypertension Investigators. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. J Hypertens 2010;28:1083-1090
8. Kon V., Ichikawa I. Glomerular circulation and function. In: Avner ED, Harmon WE, Niaudet P, eds. Pediatric Nephrology. 5th edition. Lippincott Williams & Wilkins: New York, 2004:25-44.
9. Steinbrook R., Kassirer JP. Free the data. BMJ 2010;341:811-812
10. Schaefer F., van der Walle J., Zurowska A., et al. Efficacy and safety of candesartan cilexetil suspension in hypertensive infants: the CINCH trial. Pediatr Nephrol 2009;24:1796.
11. Moffett B.S., Goldstein S.L., Adusei M., et al. Risk factors for postoperative acute renal failure in pediatric cardiac surgery patients receiving angiotensin-converting enzyme inhibitors. Pediatr Crit Care Med 2011; (In Press).